Intervention

Dose-Escalation (Phase Ia) CFT8919 capsule

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

A Phase I Study of CFT8919 in Patients With Advanced NSCLCNCT06641609 · 2024-11-04

RECRUITING

Common conditions

Non-Small Cell Lung Cancer With EGFR Mutation1

Leading sponsors

Betta Pharmaceuticals Co., Ltd.1

Trial status mix

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.